Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Oct;78(924):584-9.
doi: 10.1136/pmj.78.924.584.

Epidermal growth factor receptor and bladder cancer

A J Colquhoun  1 , J K Mellon
Affiliations
Review

Epidermal growth factor receptor and bladder cancer

A J Colquhoun et al. Postgrad Med J. 2002 Oct.

Abstract

Muscle-invasive bladder cancer is a disease which causes significant morbidity and mortality. The two main forms of treatment for this disease include radical cystectomy and radical radiotherapy, but five year survival after treatment remains low at 40%. Many clinical and molecular risk factors have been shown to be associated with poor prognosis. One such factor is the expression of epidermal growth factor receptor (EGFR), which is overexpressed by many epithelial tumours, including bladder cancers. There are several methods of inhibiting the activity of EGFR and it may be that use of an anti-EGFR therapy, in combination with more conventional treatment, provides a method of improving the prognosis for muscle-invasive bladder cancer.

PubMed Disclaimer

References

    1. J Clin Oncol. 2000 Feb;18(4):904-14 - PubMed
    1. Int J Cancer. 1993 Feb 1;53(3):365-70 - PubMed
    1. Eur J Cancer. 2001 Feb;37(3):347-54 - PubMed
    1. Clin Cancer Res. 2001 Mar;7(3):682-90 - PubMed
    1. Eur J Cancer. 2001 Sep;37 Suppl 4:S9-15 - PubMed

Publication types

MeSH terms